AMLX Latest Headlines

Amylyx Pharmaceuticals Inc (AMLX) Gets a Buy from LifeSci Capital

at www.tipranks.com (Sat, 22-Aug 3:35 PM)

Amylyx Upsizes to $500 Million Public Offering: Targeting Pipeline Growth and Avexitide Launch

Market Chameleon (Thu, 20-Aug 8:14 AM)

Amylyx Eyes Major Capital Raise: $350 Million Public Offering Targets Growth and Pipeline Progress

Market Chameleon (Wed, 19-Aug 10:31 AM)

AMLX Surges as Amylyx Sets Date for Phase 3 Results: What Does the 2026 LUCIDITY Readout Mean for Investors?

Market Chameleon (Tue, 18-Aug 10:29 AM)

Avexitide Delivers 55% Reduction in Severe Hypoglycemic Events: Amylyx Phase 3 LUCIDITY Results Set Stage for First FDA-Approved PBH Therapy

Market Chameleon (Tue, 18-Aug 7:05 AM)

Amylyx Phase 1 LUMINA Trial: Clean Safety Profile for AMX0114 Opens Door to Higher Doses in ALS

Market Chameleon (Tue, 23-Jun 9:03 AM)

Amylyx Highlights Need for New PBH Therapies with ENDO 2026 Avexitide Data Preview

Market Chameleon (Mon, 8-Jun 9:27 AM)